Biocodex Investment Portfolio

Biocodex is a family-owned French pharmaceutical group founded in 1953 that develops, manufactures and markets medicines and probiotic products, including the Saccharomyces boulardii-based brand Florastor. Headquartered in Gentilly, France, Biocodex operates internationally and supports research on the human microbiota through initiatives such as the Biocodex Microbiota Institute.